Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10

Author(s):
Engler, D.B.; Reuter, S.; Wijck, Y. van; Urban, S.; Kyburz, A.; Maxeiner, J.; Martin, H.; Yogev, N.; Waisman, A.; Gerhard, M.; Cover, T.L.; Taube, C. (0000-0002-3546-1398); Muller, A.
Published
2014
Publication type
Article / Letter to editor
bacterial immunomodulationallergy and asthma preventiontolerogenic dendritic cellsbacterial persistence determinants
Date issued
2014-08-12
Language
English
Is part of
Proceedings of the National Academy of Sciences (2014), Vol. 111, no. 32, p. 11810-11815
hdl
1887/103383
doi
10.1073/pnas.1410579111